Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Hematology International|May 31, 2024
Elranatamab treatment in a multiple myeloma patient undergoing renal dialysisZoé Van de Wyngaert, Irene Romera-Martinez, Céline Chedeville, et al.
European Journal of Haematology|December 15, 2020
Combination of brentuximab-vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T-cell lymphomaZoé Van de Wyngaert, Paul Coppo, Pascale Cervera, et al.
Frontiers in Immunology|July 10, 2024
A combination of 5-azacytidine and nivolumab is a potentially effective rescue therapy in relapsed/refractory AITLLaure Ricard, Pascale Cervera, Nicolas Stocker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 9, 2022
Photobiomodulation: a promising innovative approach for preventing oral mucositis in patients undergoing hematopoietic stem cell transplantationNicolas Stocker, Virginie Baltes, Solal Bellaiche, et al.
Clinical Hematology International|January 7, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective studyNicolas Stocker, Tamim Alsuliman, Elise Corre, et al.
Bone Marrow Transplantation|August 18, 2023
Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantationRémy Duléry, Florent Malard, Eolia Brissot, et al.
Journal of Clinical Immunology|June 1, 2024
Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell TransplantationLama Siblany, Nicolas Stocker, Laure Ricard, et al.
Bone Marrow Transplantation|October 12, 2022
Thiotepa, busulfan and fludarabine conditioning-regimen is a promising approach for older adult patients with acute lymphoblastic leukemia treated with allogeneic stem cell transplantationAnne Banet, Ali Bazarbachi, Myriam Labopin, et al.
Leukemia & Lymphoma|April 23, 2022
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center studyMara Memoli, Alexis Genthon, Fabrizia Favale, et al.
Clinical Hematology International|May 31, 2024
Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impactAnnalisa Paviglianiti, Tânia Maia, Joël-Meyer Gozlan, et al.
Pageof 3